Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.

Steffes MW, Sibley S, Jackson M, Thomas W.

Diabetes Care. 2003 Mar;26(3):832-6.

PMID:
12610045
5.

The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.

Winocour PH, Jeacock J, Kalsi P, Gordon C, Anderson DC.

Diabetes Res Clin Pract. 1990 Apr;9(1):23-35.

PMID:
2351037
6.

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.

Diabetes. 2004 Jan;53(1):250-64. Erratum in: Diabetes. 2004 Jul;53(7):1934.

9.

Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.

Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J.

Pediatr Diabetes. 2009 May;10(3):168-76. doi: 10.1111/j.1399-5448.2008.00472.x. Epub 2008 Oct 22.

PMID:
19175900
10.

Metabolic effect of islet B-cell function in insulin-treated diabetes.

Gjessing HJ, Matzen LE, Iversen S, Faber OK, Frøland A.

Scand J Clin Lab Invest. 1989 Jun;49(4):337-43.

PMID:
2662383
11.

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

Schnell O, Eisfelder B, Standl E, Ziegler AG.

Diabetes. 1997 Oct;46(10):1607-11.

PMID:
9313757
13.
14.
15.

Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy.

Nakanishi K, Kobayashi T, Inoko H, Tsuji K, Murase T, Kosaka K.

Diabetes. 1995 Nov;44(11):1334-9.

PMID:
7589833
16.

Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.

Diabetes Care. 2006 May;29(5):1031-8.

PMID:
16644633
17.

Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study.

Verrillo A, de Teresa A, Martino C, Verrillo L, di Chiara G.

Diabetes Res. 1988 Jun;8(2):71-6.

PMID:
3067950
19.

Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.

Raz I, Avron A, Tamir M, Metzger M, Symer L, Eldor R, Cohen IR, Elias D.

Diabetes Metab Res Rev. 2007 May;23(4):292-8.

PMID:
17124720
20.

Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.

Tung YC, Lee JS, Tsai WY, Hsiao PH.

Eur J Pediatr. 2008 Jul;167(7):801-5. Epub 2007 Sep 15.

PMID:
17874132

Supplemental Content

Support Center